NL-OMON20228已完成不适用
The effect of glycopyrroniumbromide on hypersalivation in patients with Parkinson's disease: a randomised, cross-over, doubleblind, placebocontrolled trial.
M.E.L. Arbouw, Hospital Medisch Spectrum TwenteDepartment of clinical pharmacyP.O. Box 50.0007500 KA EnschedeThe Netherlands0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 24
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patients with Parkinson's disease;
- •2. Age >=18 years;
排除标准
- •1. Hypersensitivity to glycopyrronium bromide, sorbic acid or saccharin sodium;
- •2. Myasthenia gravis;
研究者
相似试验
已完成
2 期
The effect of glycopyrronium bromide on hypersalivation in patients with Parkinson's disease: a randomised, cross-over, double-blind, placebo controlled trial.NL-OMON30532Medisch Spectrum Twente24
已完成
不适用
The effect of glycopyrronium bromide on hypersalivation in patients with Parkinson's disease: a randomised, cross-over, double blind, placebo-controlled trialParkinsonian patients, hypersalivationNervous System DiseasesExtrapyramidal and movement disordersISRCTN28592111Hospital Medisch Spectrum Twente (The Netherlands)23
已完成
不适用
Effects of allopurinol mouthwash and rebamipide gargle for stomatitis occurred during radiation therapy for cancer and cancer chemotherapyOral cancerJPRN-UMIN000011759Oral and Maxillo Facial Surgery, National Defense Medical College60
已完成
不适用
The effect of glycopyrroniumbromide oral solution for nocturnal drooling due to the use of clozapine.English: CIS, clozapine-induced-sialorrhea, hypersalivation, droolingNederlands: sialorroe, hypersalivatie, kwijlenNL-OMON26368Mw. Dr. Ingeborg WiltingziekenhuisapothekerUniversitair Medisch Centrum Utrechtziekenhuisapotheek33
进行中（未招募）
不适用
The effect of glycopyrroniumbromide oral solution for nocturnal drooling due to the use of clozapineEUCTR2012-002299-15-NLniversitair Medisch Centrum Utrecht